title: Organogenetic tolerance.
abstract: Transplantation therapy for humans is limited by insufficient availability of donor organs and outcomes are complicated by the toxicity of immunosuppressive drugs. Xenotransplantation is a strategy to overcome supply problems. Implantation of tissue obtained early during embryogenesis is a way to reduce immunogenicity of transplants. Insulin-producing cells originating from embryonic pig pancreas obtained very early following initiation of organogenesis [embryonic day 28 (E28)] engraft long-term in non-immune suppressed diabetic rats or rhesus macaques. Recently, we demonstrated engraftment of morphologically similar cells originating from adult porcine islets of Langerhans (islets) in rats previously transplanted with E28 pig pancreatic primordia. Our findings are consistent with induction of tolerance to a cell component of porcine islets induced by previous transplantation of embryonic pig pancreas, a phenomenon we designate organogenetic tolerance. Induction of organogenetic tolerance to porcine islets in humans with diabetes mellitus would enable the use of pigs as islet donors with no host immune suppression requirement. Adaptation of methodology for transplanting embryonic organs other than pancreas so as to induce organogenetic tolerance would revolutionize transplantation therapy.
authors.affiliation: Renal Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. mhammerm@dom.wustl.edu
authors.forename: Marc R
authors.initials: MR
authors.lastname: Hammerman
mesh_terms: D000818:Animals; D006801:Humans; D007108:Immune Tolerance; D038081:Organogenesis; D051381:Rats; D013552:Swine; D014183:Transplantation, Heterologous